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Abstract
Objectives:This population-based analysis examined the prevalence of periodontal
diseases along with the self-perceived oral health and patterns of dental care utiliza-
tion of breast cancer survivors in the United States.
Methods:Data from the 1999-2004NationalHealth andNutrition Surveyswere uti-
lized, examining information from 3,354 women between 50 and 85 years of age.
Primary outcomes were gingivitis and periodontitis, self-perceived oral health, and
dental care utilization. Logistic regression analyses were used to estimate relation-
ships of breast cancer diagnosis and primary outcomes while controlling for con-
founding factors.
Results: Breast cancer survivors were more likely to be older than 55 years, white,
nonsmokers, have higher levels of education and income, and a higher prevalence of
osteoporosis. Breast cancer survivors were significantly less likely to have dental
insurance (P = 0.04).Utilization of dental services and reason for last dental visit did
not significantly differ between groups.A history of a breast cancer diagnosis did not
increase the odds of gingivitis [odds ratio (OR): 1.32; 95 percent confidence interval
(CI): 0.53-3.63], periodontitis (OR: 1.82; 95 percent CI: 0.89-4.01), or poor self-
perceived oral health (OR: 0.89; 95 percent CI: 0.61-1.33) after adjusting for age,
race, education, dental care utilization, and smoking status.
Conclusions: In this sample, a history of breast cancer does not significantly impact
periodontal health, self-perceived oral health, and dental care utilization. However,
efforts should be made to assure that breast cancer survivors have dental insurance.
Introduction
Breast cancer affects one in eight American women over the
course of their lifetime. Breast cancer occurs more frequently
in postmenopausal women than in premenopausal women;
and themedian age at diagnosis in the United States is 61 (1).
For most women diagnosed with breast cancer, the 5-year
survival rate is over 80 percent (1). The acute oral effects of
chemotherapy and radiation include mucositis, xerostomia,
caries, bleeding, and periodontal disease (2). However, long-
term complications and late effects of cancer treatments on
oral health are currently unexplored (3).
Postmenopausal breast cancer survivors are particularly
vulnerable as their age places them at an increased risk for
declining oral health in addition to experiencing skeletal
complications of cancer therapy (4,5). Research showed that
chemotherapy and glucocorticoids, used to decrease the
nausea associated with chemotherapy, accelerate skeletal
bone loss (4) and that anti-estrogen therapy can be associ-
ated with bone loss (6). Systemic anti-estrogen use in
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postmenopausal women includes the use of tamoxifen and
aromatase inhibitors (AIs) (7). AI use is associated with sig-
nificant declines in bone mineral density (BMD) (8).
Reduced estrogen levels such as those in postmenopausal
women have been linked to the pathogenesis of periodontal
disease (5). The fact that low BMD is cited as a risk factor
for periodontitis suggests that cancer therapies may be a risk
factor for periodontitis (9-11).
Understanding factors that can affect breast cancer
survivors’ quality of life is important (12). Oral pain and
xerostomia have significant effects on reducing the oral
health-related quality of life (OHRQoL) and functional
capabilities of patients and, in some, nutritional status
(13,14). Moreover, self-perceived oral health has been
shown to be a key determinant of dental care and overall
health satisfaction (15).
Breast cancer survivors have been shown to receive fewer
preventive services such as influenza vaccinations, cholesterol
screening, and bone densitometry than age-matched controls
due to the cancer diagnosis shifting attention away from
noncancer routine medical services (16). Although under-
standing dental care utilization patterns in this population is
critical for the assessment of oral health among breast cancer
survivors, the utilization patterns of this population remain
largely unknown.
As there is a lack of evidence concerning breast cancer sur-
vivors’ oral health, the objectives of this population-based
analysis were to determine the prevalence of periodontal dis-
eases, the perceived oral health, and the patterns of dental care
utilization inwomen ages 50-85with andwithout a history of
breast cancer in the United States.
Methods
Database
The Institutional Review Board at the University of Michigan
declared this study to be exempt becauseNational Health and
Nutrition Surveys (NHANES) are publicly available and the
data are de-identified.Data for this study were obtained from
the NHANES 1999-2000, 2001-2002, 2003-2004 public
datasets (17). The NHANES are designed to obtain
information on the health and nutritional status of the
noninstitutionalized population of the United States and are
conducted by the National Center for Health Statistics. The
sampling plan of each of the NHANES followed a highly
stratifiedmultistage probability design inwhich a sample was
selected to provide national estimates. Methods for the stan-
dardized interviews, dental examinations, and procedures for
human protection and consent have been described in detail
elsewhere (17).
The starting sample for this analysis was 3,354 women
50-85 years who had participated in the examination part in
the NHANES 1999-2004 and for whom valid questionnaire
and cancer data were available.A total of 177 of these women
identified themselves as breast cancer survivors; the rest of the
women did not indicate that they were survivors of any kind
of cancer (n = 3,177). Although the results presented in
Tables 1 and 2 were based on data from the 3,354 women, an
additional 266 participants were excluded from the peri-
odontal estimates because they had not received a dental
examination. In addition, 94 women had to be excluded
because within their dental examinations, they had not
received a periodontal examination. The results in Table 3
and the periodontal regression analyses models were there-
fore based on data from 2,994 females (164 breast cancer sur-
vivors and 2,830 women without any cancer).
Breast cancer diagnosis and age of diagnosis
The independent variable, self-reported breast cancer diag-
nosis, was determined from the health questionnaire section
of the examination interview conducted at themobile exami-
nation center (MEC). The questions were as follows: “Have
you ever been told by a doctor or other health professional
that you had cancer or amalignancy of any kind?”and“What
kind of cancer was it?”Only those respondents who indicated
they had breast cancerwere eligible for inclusion.Participants
who indicated any other type of cancer were ineligible. The
respondent’s age at the time of breast cancer diagnosis was
also available.
Outcome measures
Periodontal conditions
The NHANES dental health examinations have been
described previously (18,19). Dental examinations were con-
ducted by standardized examiners in the MEC. The peri-
odontal status of individuals in NHANES was assessed using
randomly assigned half-mouths (one upper and one lower
quadrant) for each individual using a NIDCR periodontal
probe. Periodontal examination data between the NHANES
differed. The 1999-2000 protocol specified attachment loss,
periodontal pockets assessments at two sites per tooth, and
the gingival sweep was used to assess gingival bleeding at the
quadrant level, whereas in the 2001-2002 and in the 2003-
2004 surveys, periodontal pocket depth, clinical attachment
loss (CAL), and periodontal bleeding were taken at three sites
per tooth (18,19). In this analysis, to increase comparability
between NHANES protocols, only two sites (mid facial and
mesial facial) were analyzed. Gingivitis was defined as the
presence or absence of gingival bleeding in one ormore quad-
rants or one or more sites.We defined moderate periodontal
disease as two or more interproximal sites with ≥4 mm of
CAL or two ormore interproximal sites with a probing depth
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≥5 mm (not on the same tooth) and severe periodontitis as
two ormore interproximal sites with CAL ≥6 mm,not on the
same tooth, and one or more interproximal sites with PD
≥5 mm following previously published reports (20).
Perceived oral health
Perceived oral health was assessed by asking the respondents
to assess their oral health on a 4-point scale (1 = poor, 2 = fair,
Table 1 Demographic and Clinical Characteristics of US Women Ages 50-85 NHANES Stratified by
Breast Cancer Status, 1999-2004
Characteristic
Breast cancer No cancer
n = 177 (5.5%) n = 3,177 (94.5%)
Obs % SE Obs % SE P-value
Age
50-55 years 16 16.1 4.3 765 39.5 1.1
56-65 years 44 28.6 4.8 1,040 27.8 1.2
66-75 years 52 31.8 4.4 704 20.9 1.0
76-85 years 65 23.5 4.1 668 11.8 0.8 <0.001
Ethnicity
White 133 89.2 2.2 1,706 75.8 2.0
Black 21 5.9 1.3 571 10.3 1.0
Hispanic & Mexican American 23 4.9 1.6 900 13.9 1.8 <0.001
Education
Less than high school 51 20.9 3.0 1,305 27.5 0.95
High school diploma 52 34.2 4.3 780 28.7 0.91
More than high school 74 44.9 4.2 1,066 43.8 1.22 0.47
Poverty income ratio*
PIR <= 1.350 35 19.3 3.4 864 23.4 1.3
PIR > 1.351 & PIR <= 3.500 63 44.2 5.0 116 38.1 1.7
PIR > 3.501 50 36.5 5.1 779 38.5 1.5 0.43
Smoking status
Current 17 12.7 2.5 394 14.2 0.88
Past 64 36.7 4.6 836 28.2 0.88
Never 96 50.6 4.2 1,933 57.6 1.2 0.12
Diagnosis of osteoporosis
Yes 49 35.3 1.1 556 16.9 0.58
No 125 64.7 1.0 2,601 83.1 0.58 <0.001
Diabetes
Yes 34 16.3 3.2 2,644 12.8 0.78
No 143 83.7 3.2 528 87.2 0.78 0.24
Cancer characteristics
Mean age diagnosis† 177 62.9 NA
Mean time since diagnosis‡ 170 9.9 NA
Dental characteristics
Has dental insurance
Yes 62 41.4 4.8 1,378 51.9 1.6
No 110 58.6 4.8 1,506 48.1 1.6 0.04
Last dental visit
<=12 months 107 66.0 4.9 1,644 52.5 1.6
12-35 months 29 16.8 3.8 572 18.2 0.75
36-59 months 40 17.2 3.1 920 29.3 0.83 0.17
Reason for last dental visit
Checkup 96 56.9 4.1 1,360 49.4 1.30
Emergency 44 23.5 4.2 1,134 32.5 1.07
Scheduled 33 19.6 3.5 629 18.1 0.71 0.14
* Poverty income ratio is the ratio based on family income, family size, and number of children in the
family, for families with two or fewer adults, and on the age of the adults in the household.
† Mean age of cancer diagnosis (range 37-85 years; SD ± 10.8 years).
‡ Mean time since diagnosis (range 0-35 years; SD ±7.1 years) ± Not all variables add to column
number due to nonresponse.
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3 = good, 4 = excellent). In addition, the respondents indi-
cated how often their oral health limits the kind of food they
ate (5-point scale with 1 = never, 2 = seldom, 3 = sometimes,
4 = often, 5 = always), and whether their mouth was dry
when eating (yes/no). The last question was the perceived
amount of saliva, which was measured as “too little,” “too
much,”or “did not notice.”
Dental care utilization
Dental care utilization was divided into a dental visit within
the last 12 months, 13-35 months ago, and longer than 35
months ago. Participants who had visited the dentist were
asked to indicate whether their visit had been for a check-up,
an emergency, or a scheduled appointment.Dental insurance
status was assessed as yes/no.
Putative confounders
Factors that have been shown to be associatedwith periodon-
tal disease were evaluated for confounding and effect modifi-
cation. Variables obtained from the face-to-face interview
included age (50-55, 56-65, 66-75, 76-85 years). Race/
ethnicity was categorized as the following mutually exclusive
categories – non-Hispanic white, Mexican American and
other Hispanic and non-Hispanic black. Other race/
ethnicities were excluded from the analysis due to the small
numbers of respondents. Education level was categorized as
less than 12 years of education, 12 years of education, or
greater than12 years of education.Poverty income ratio (PIR)
is the ratio of family income to poverty threshold for a given
family size and composition. Guidelines are issued each year
in the Bureau of the Census, Department of Commerce. For
this analysis, PIR was categorized as (low: 0. 00-1. 350,
medium: 1. 351-3.500, high: ≥3.501) based on suggested
NHANES analytical guidelines (21). Smoking status was
obtained from two questions: Have you smoked at least 100
cigarettes in life? and (2) do you now smoke cigarettes?
Smoking was defined as current, past, and never smoker. Self-
reported osteoporosis diagnosis was reported as yes/no. Age
of breast cancer diagnosis was a continuous variable, and
length of time since diagnosis was categorized as 0-5 years,
6-11 years, and 12 andmore years.
Descriptive statistics were performed for all variables.
Bivariate measures of unadjusted association between breast
cancer diagnosis and periodontal outcomes (gingivitis/
periodontitis), dental utilization, and perceived oral health
were assessed with the Pearson chi-square test and t-test.
Given the small sample of breast cancer survivors in
NHANES 1999-2004 data sets, adjustment for potentially
confounding factors in multivariate models was purposely
limited. Multiple logistic regression analysis utilizing the
Table 2 Perception of Oral Health Responses of Respondents with and
without a Cancer Diagnosis (n = 3,354)
Perceived oral health Breast cancer No cancer P-value*
characteristic n = 177% (SE) n = 3,177% (SE)
Perception of oral health
Excellent 30.6 (4.7) 24.9 (1.3)
Good 40.5 (4.5) 37.7 (1.0)
Fair 22.9 (4.9) 22.3 (0.9)
Poor 6.0 (2.9) 15.1 (0.1) 0.04†
Limited foods due to teeth/mouth?
Always 2.1 (2.0) 3.9 (0.6)
Often 1.7 (0.3) 2.7 (0.3)
Sometimes 12.2 (3.1) 10.4 (0.7)
Seldom 6.5 (1.6) 9.6 (1.0)
Never 77.5 (4.6) 73.4 (1.4) 0.18
Amount of saliva in mouth
Too little 9.3 (2.8) 8.4 (0.5)
Too much 6.3 (1.9) 4.8 (0.5)
Did not notice 84.4 (3.4) 86.8 (0.8) 0.71
Dry mouth when eating?
Yes 6.2 (2.2) 5.2 (0.5)
No 93.8 (2.3) 94.8 (0.4) 0.62
* P-value from chi-square test of association comparing breast cancer
and no cancer groups.
† Indicates statistical significance.
SE, standard error.
Table 3 Periodontal Characteristics of Postmenopausal Women Aged
50-85 Years, by Breast Cancer Diagnosis (n = 2,994)
Periodontal measure
Breast cancer No cancer
P-valuen = 164 n = 2,830
% (SE)* % (SE)*
Gingivitis 48.1 (1.2) 44.2 (3.1) 0.12†
Periodontitis – moderate 16.5 (3.0) 12.4 (0.98) 0.39†
Periodontitis– severe 3.6 (1.2) 4.2 (0.63) 0.61†
Gingival bleeding 4.1 (0.13) 3.5 (0.08) 0.73†
Probing depths 4mm (%) 28.6 (1.7) 23.4 (1.2) 0.39†
Mean (SE)* Mean (SE)* P-value
Maximum attachment loss (mm)¶ 3.3 (0.35) 3.2 (0.07) 0.69‡
Mean attachment loss (mm)¶ 1.2 (0.04) 1.1 (0.02) 0.89‡
Maximum probing depth 2.2 (0.09) 2.4 (0.06) 0.74‡
Mean probing depth 2.5 (0.35) 2.4 (0.11) 0.33‡
Mean number of teeth 15.0 (1.0) 17.1 (0.34) 0.07§
Periodontitis – moderate: ≥2 or more interproximal sites with ≥4 mm
clinical attachment loss (not on the same tooth) or ≥ 2 interproximal sites
with probing depth a ≥5 mm (not on the same tooth).
Periodontitis – severe: ≥2 interproximal sites with clinical attachment loss
of ≥6 mm (not on the same tooth) and ≥1 interproximal sites with
probing depth ≥5 mm.
* SE: standard error of the mean.
† Comparisons were carried out using chi-square test of association.
‡ Comparisons were carried out using the two sample t-test.
¶ mm = millimeter.
§ Comparisons were carried out using a two-sample Wilcoxon rank-sum
(Mann–Whitney) test.
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manual backward selection method was used to assess the
relationship between breast cancer diagnosis and periodontal
outcomes while controlling for other covariates. A threshold
P-value of 0.20 for removal of a variablewas usedwhenbuild-
ing the model in a backward stepwise manner. However, all
decisions for inclusion of variables were based on clinical and
statistical significance. Potential interactions between breast
cancer diagnosis and covariates were also examined using the
Mantel–Haenszel chi-square test of association. No signifi-
cant interactions were found for any models; therefore, only
the main effects models are reported. All analyses were con-
ducted using a software package STATA v. 13, (STATACorpo-
ration, College Station, TX, USA) to adjust for complex
sampling design and examination sampling weights and to
provide adjusted variance estimations. Thus, the number of
participants per category is unweighted, whereas all means,
percentages, and ORs are weighted to reflect the target popu-
lation and standard errors and 95 percent CIs are adjusted for
sampling design.
As nearly 11 percent of women ages 50-85 did not receive a
complete periodontal examination, multiple-imputation
analysis (22) was used to examine whether results based on
the complete-case analyses remained stable after imputation
of missing values and to allow for greater statistical power to
detect associations of interest between the analysis variables.
Using IVEware software (Imputation and Variance Estima-
tion Software, Institute for Social Research, Ann Arbor, MI,
USA) 20 imputed datasets were generated and then averaged
to generate a final overall dataset. The resulting associations
behaved no differently than in the models without imputa-
tion, therefore only the complete case analysis was provided.
Results
Descriptive characteristics for the full sample of 3,354 US
women ages 50 years and older stratified by breast cancer
status are presented in Table 1. It is important to note that
these same analyses were also conducted with data from the
restricted sample of 2,994women for whomperiodontal data
were available.However, the comparisons of the results based
on the full sample and the results based on the restricted
sample showed that the two sets of analyses did not differ in
the outcomes of the group comparisons. This lack of differ-
ences concerning whether the two groups differed in the
characteristics analyzed reflect that no major changes in the
percentages of responses had been found when the data from
the restricted sample were compared with the percentages of
responses from the full sample.
Approximately, 5.5 percent of our sample reported a diag-
nosis of breast cancer. The average age at diagnosis was 62.9
years (±10.8 standard deviation) and the range was 37-85
years. The average time since diagnosis was 9.9 years ± 7.1
years; range 0-35 years.
Breast cancer survivorsweremore likely to be older than 66
years (P < 0.001), more likely to be Non-Hispanic white
(P < 0.001), and had a higher prevalence of osteoporosis
(35.3 percent versus 16.9 percent; P < 0.001) as compared
with unaffected women. The groups did not differ in their
level of education, PIR, smoking status, or prevalence of dia-
betes. Breast cancer survivors were less likely to have dental
insurance than women without a breast cancer diagnoses
(38.7 percent versus 49.1 percent;P = 0.04).However, the two
groups did not differ in the percentages of women with a
dental visit nor in the reasons for these visits.
Table 2 presents the results of bivariate analyses of the
responses to the four OHRQoL questions. Women with a
history of breast cancer diagnosis perceived their oral health
more positively than women without a breast cancer diagno-
sis (P = 0.04). The respondent’s perception as to the amount
of saliva they reported to have in general and when eating did
not differ according to cancer diagnosis.
Table 3 provides an overview of the periodontal param-
eters for women with and without breast cancer diagnosis.
The prevalence of gingivitis of breast cancer survivors was
48.1 percent (nonbreast cancer respondents: 44.2 percent)
and the prevalence of periodontitis was 16.5 percent
(nonbreast cancer respondents: 12.4 percent). There were no
significant differences in the periodontal pocket depths and
attachment loss parameters of the two groups. A trend was
found related to the mean number of teeth present with
breast cancer survivors having on average 15.0 teeth present
as compared with nonbreast cancer participants who have
17.1 teeth present (P = 0.07).
Multivariate analyses describing the periodontal health,
perceived oral health, and dental utilization practices of sur-
vivors are shown inTable 4.The periodontal health outcomes
and oral health models were adjusted for age, race/ethnicity,
education, dental visit within 12 months, and smoking. For
the dental utilization model, as dental utilization was the
outcome of interest, health insurance status was placed in the
model as a covariate. As the prevalence of severe periodontal
disease was low in both groups of women (see Table 3), no
multivariate analysis with the dependent variable “severe
periodontitis” was possible. Therefore, for the multivariate
models, periodontitis was defined as including both moder-
ate and severe periodontal disease.
Having had a breast cancer diagnosis was not associated
with an increase in the odds of either gingivitis [odds ratio
(OR): 1.24; 95 percent confidence interval (CI): 0.64, 2.53]
or periodontitis (OR: 1.7; 95 percent CI: 0.96, 3.02) in either
the unadjusted or adjusted models. Being nonwhite,
smoking, and having a dental visit more than 12 months ago
were associated with the odds of periodontitis after control-
ling for other covariates.
A breast cancer diagnosis was inversely associated with a
woman’s oral health perception (OR: 0.68; 95 percent
Breast cancer survivors’ oral health L.S. Taichman et al.
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CI: 0.48, 0.96) in unadjusted analyses. However, the relation-
ship between cancer diagnosis and perception of oral health
was attenuated after adjusting other factors (OR: 0.89; 95
percent CI: 0.61, 1.33) (Table 4). Having lower educational
attainment, being a current smoker, and being nonwhite were
strongly associated with a higher probability of a lower per-
ception of oral health.
A diagnosis of breast cancer was not associated with
having a dental visit within the last year. Having higher
educational attainment and being a current smoker and
having dental insurance were significantly associated
with a higher likelihood of having a dental visit within the last
year.
Discussion
The aim of this study was to examine the relationship
between a breast cancer diagnosis and periodontal diseases,
perceived oral health, and dental care utilization using a large
population based representative sample in the United States.
This research is the first study that specifically investigated the
oral health status of postmenopausal breast cancer survivors.
Prevalence estimates of breast cancer for women with
breast cancer diagnoses in our study were slightly higher than
those reported in two other studies that also used NHANES
data to examine women diagnosed with breast cancer versus
not having such a diagnosis (23,24). Both of these studies
Table 4 Weighted Estimates of Crude and Adjusted Odds Ratios and Designed-Based 95% CI, of the Association of Cancer Diagnosis and Periodontal
Measures, Perceived Oral Health, and Dental Visit within the Last 12 Months
Dependent variable
Gingivitis* Periodontitis†
Perception of
oral health‡ Dental utilization§
Characteristics OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Unadjusted estimates
Breast cancer diagnosis 1.24 0.64-2.53 1.7 0.96-3.02 0.68 0.48-0.96 0.80 0.53-1.24
Adjusted estimates
Cancer diagnosis 1.32 0.53-3.62 1.82 0.89-4.01 0.89 0.61-1.33 0.73 0.43-1.21
Age
50-55 years 1.0
56-65 years 0.70 0.56-0.98 1.0 0.59-1.7 0.87 0.69-1.10 1.3 0.97-1.90
66-75 years 0.76 0.55-1.23 1.1 0.61-1.8 0.78 0.61-1.04 1.4 1.01-1.93
76-85 years 0.87 0.55-1.54 0.73 0.43-1.3 0.65 0.46-0.89 2.0 1.54-2.85
Ethnicity
White (Ref) 1.0 1.0 1.0 1.0
Black 1.13 0.66-1.72 1.7 1.2-2.6 1.9 1.52-2.45 1.8 1.41-2.22
Hispanic & Mexican-American 1.52 0.92-2.43 2.0 1.3-3.1 2.0 1.44-2.71 1.4 0.94-2.04
Education
<High school (Ref) 1.0 1.0
High school 0.96 0.50-1.44 0.82 0.50-1.4 0.70 0.53-0.92 0.51 0.36-0.72
>High school 1.01 0.63-1.42 0.90 0.48-1.6 0.52 0.40-0.66 0.25 0.18-0.34
Smoking status
Never 1.0 1.0 1.0 1.0
Former 1.07 0.61-1.70 1.1 0.67-1.8 1.1 0.83-1.34 0.94 0.76-1.25
Current 1.09 0.64-1.52 2.0 1.24-3.4 1.8 1.32-2.35 1.7 1.22-2.32
Last dental visit
>12 months 1.0 1.0 1.0
<=12 months 0.74 0.53-1.14 0.47 0.44-0.68 0.55 0.33-0.67 Outcome
Dental insurance
Yes 0.73
No 1.0 0.59-0.92
* The gingivitis model was adjusted for age, race/ethnicity, education, having dental visit within 12 months, and smoking status (n = 2,994).
† Periodontitis includes both moderate and severe cases. The periodontitis model was adjusted for age, race/ethnicity, education, smoking status, and
having dental visit within past 12 months (n = 2,994).
‡ Perception of oral health was assessed on a 4-point scale ranging from 1 = “poor” to 4 = “excellent oral health.” Perception of oral health models
were adjusted for age, race/ethnicity, education, dental visit within 12 months, and smoking status (n = 3,312).
§ For the dental utilization regression model, as dental utilization is the outcome of interest, the model was adjusted for age, race/ethnicity, education,
presence of dental insurance, and smoking status (n = 2,956).
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found that approximately 4 percent of the women had been
diagnosed with breast cancer, whereas we identified 5.5
percent of women with breast cancer diagnoses in our
sample. However, this difference is most likely due to the fact
that these two studies included data from women 35 years
and older, whereas only data fromwomen 50 years of age and
older were included in our study. Similarly to our findings,
these two publications also found that womenwith a diagno-
sis of breast cancerwere significantly older than thosewith no
history of cancer (64.5 years versus 53.3 years). In addition,
the results from our study are also consistent with the find-
ings from the two previous studies in finding an average time
since diagnosis of nearly 10 years.
Approximately 66 percent of survivors reported a dental
visit within the last year. This finding is consistent with the
results of the 2000-2004 Medical Expenditure Panel Survey
that also showed that 66 percent of breast cancer survivors
had a dental visit within the past year (25). It is important in
this context to note that breast cancer survivors in our sample
were significantly less likely to report having dental insurance
than women without a cancer diagnosis. This finding might
be due to fact that the respondents in the breast cancer group
were older than thewomen in the control group and thusmay
be less likely to have no dental insurance due to retirement or
to not being employed.
However, the finding of women diagnosed with breast
cancer being less likely to have dental insurance but neverthe-
less having a high utilization rate is inconsistent with findings
in other areas of health care: Other studies showed that
women with breast cancer diagnoses were less likely to have
preventive care such influenza shots (16) than women
without a cancer diagnosis.However,other authors examined
the question of whether a breast cancer diagnosis modifies
care-seeking behavior for comorbid conditions among older
adults (26,27). It has been speculated that once a woman
becomes engaged in the healthcare system, they are likely to
remain engaged (28). Future research should explore which
factors determine preventive dental care utilization pattern
among breast cancer survivors because good oral health is an
important factor for the overall oral health of this population.
Interestingly, women who had a breast cancer diagnosis
had a significantly better perception of their oral health than
women without a cancer diagnosis in unadjusted analysis.
However, the relationship was attenuated after controlling
for confounding factors. Although we could not find any
studies exploring the oral health perceptions of women with
versus without a breast cancer diagnosis, a 5 year investiga-
tion of bisphosphonate zolendronic acid therapy in breast
cancer patients assessed the women’s OHRQoL at the
completion of the study. The authors found no difference in
the prevalence of impacts on oral health between patients
with breast cancer diagnoses who had used versus not used
zoledronate (29).
One explanation for our findings of no difference in per-
ception of oral health could be that in a population with a
cancer diagnosis, oral health problems play a secondary role
in those with potentially life-threatening health problems
(29).A feeling of mouth dryness while eating has been shown
as a strong risk factor associated with poorOHRQOL (30). In
our sample, the majority of cancer survivors indicated that
their amount of saliva was “just right.” As self-perceived oral
health is shown to be a key determinant of food selection and
dental care (31), further investigations into cancer treatments
and OHRQoL are warranted.
Our results show no association between gingivitis or
periodontitis and having had breast cancer among post-
menopausal women. One possible explanation for this
negative finding may be the consistent use of regular pre-
ventive dental services by breast cancer survivors. Another
possibility for the lack of an association may be related to
the predominant use of tamoxifen in this sample. Nearly 79
percent of women with a breast cancer diagnosis with a
periodontal examination reported the use of tamoxifen.
Before 2002, tamoxifen was the most prescribed anti-
estrogen drug for postmenopausal women with estrogen
receptor-positive breast cancers (32). At present, no clinical
data are available regarding the impact of tamoxifen and
oral health. However, human gingival fibroblasts are
a target tissue for sex hormones, and in vitro studies have
demonstrated that tamoxifen may decrease the stimulatory
effect of estrogen on human gingival fibroblast proliferation
(33). Guidelines recommend that AIs are to be used at
some point during the treatment of estrogen receptor-
positive early-stage breast cancer in postmenopausal women
(34). As AI use is associated with significant skeletal BMD
loss (35) and oral bone correlates with skeletal BMD,
women may be at risk for oral bone loss with the use of AIs
(36, 37).
Limitations of this analysis include the cross-sectional
design that prevents the determination of causality. Another
potential limitation is healthy participation bias.Womenwho
had received periodontal exams were more likely to be
younger than 60 years of age, non-Hispanic white, married,
have higher levels of education and family incomes, be non-
smokers, and report having dental insurance. Women were
less likely to have a periodontal examination if they self-
reported diabetes, osteoporosis, or cancer.Another limitation
involves the representativeness of the breast cancer partici-
pants in NHANES for all women with a history of breast
cancer. Also roughly 11 percent of women ages 50-85 did not
have a complete periodontal examination severely limiting
the robustness of the periodontal models. To address this, a
multiple imputation techniquewas used for themissing peri-
odontal variables. However, the resulting associations were
essentially the same as in the models without imputation,
leading us to believe that there is no association between
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diagnosis of breast cancer and periodontal diseases in this
sample. Finally, the use of partial-mouth periodontal exami-
nation within the NHANES is recognized to underesti-
mate periodontal disease prevalence resulting in disease
misclassification thus attenuating the strength of the associa-
tion between breast cancer diagnosis and periodontal condi-
tions (38). Furthermore, the small number of breast cancer
survivors coupled with the small number of periodontal
examinations may have affected our ability to effectively
capture the association between a breast cancer diagnosis and
periodontal disease.
Another limitation of this analysis is the lack of informa-
tion related to breast cancer treatments. The rationale and
selection of breast cancer treatments is complex and based
on many prognostic and predictive factors including tumor
histology and grade, the clinical and pathologic stage, lymph
node involvement, tumor hormone receptor content, tumor
HER2 status, comorbid conditions, age, and patient prefer-
ence. As such, there is likely great variation in the breast
cancer treatments that these breast cancer survivors
received. Also, as chemotherapy often accelerates skeletal
bone loss, women counteract these effects by taking supple-
mental doses of calcium and vitamin D, which was not
addressed in this analysis. Finally, The NHANES may dis-
proportionately include long-term survivors (10 years or
more) compared with the general population that includes
women who have shorter survival periods.
Despite these limitations, a notable strength of this study
is the diverse age and ethnicity of this national representa-
tive sample of US women. Of importance is the finding that
breast cancer survivors are significantly less likely to have
dental insurance compared to postmenopausal women
without a cancer diagnosis. However, breast cancer survi-
vors demonstrate regular preventive dental attendance
that in turn may impact their overall perception of oral
health.
Although a history of breast cancer was not associatedwith
an increased prevalence of periodontal disease in this analy-
sis, there is still a need for further examination of the
impact of specific cancer treatment agents on the oral
health and OHRQoL of postmenopausal breast cancer survi-
vors. Prospective clinical studies assessing the specific role of
breast cancer treatments, particularly chemotherapy and
anti-estrogen therapies, are needed to elucidate the relation-
ship between a breast cancer diagnosis and oral health
status.
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